Monitoring asparaginase activity to improve the management of patients with acute lymphoblastic leukemia: Experience in one center

An Pediatr (Engl Ed). 2024 Jan;100(1):65-66. doi: 10.1016/j.anpede.2023.09.016. Epub 2024 Jan 3.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Asparaginase / therapeutic use
  • Humans
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy

Substances

  • Asparaginase
  • Antineoplastic Agents